Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies

The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection

(2015) Benjamin P. Linas et al.   ANNALS OF INTERNAL MEDICINE

Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus

(2015) Mehdi Najafzadeh et al.   ANNALS OF INTERNAL MEDICINE

Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States

(2015) Jagpreet Chhatwal et al.   ANNALS OF INTERNAL MEDICINE

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals

(2014) Liesl M. Hagan et al.   HEPATOLOGY

Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatment

(2014) Hans L Tillmann   WORLD JOURNAL OF GASTROENTEROLOGY

Screening for HIV: Systematic Review to Update the 2005 U.S. Preventive Services Task Force Recommendation

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention

(2013) Bryce D. Smith et al.   ANNALS OF INTERNAL MEDICINE

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE